Alzheimer’s treatment roadblocks can be eased by engaging primary care providers in screenings
There is substantial geographic variation across the U.S. health care system to diagnose and treat early-stage Alzheimer’s disease with disease-modifying therapies, and engaging primary care providers in the effort may be a key to accelerating delivery of emerging new treatments, according to a new RAND report.
Enabling primary care practitioners to diagnose and evaluate patients for treatment eligibility would make the biggest impact on reducing wait times for specialists and increase the number of people treated with disease-modifying therapies from 2025 through 2044.
While primary care providers are technically capable of performing cognitive assessments, ...












